Callos Andrew bought CYTK
December 8, 2025 · Form 4 insider transaction
Callos Andrew bought 1,042 shares of Cytokinetics, Incorporated at $39.13 per share, a transaction worth $40.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,042
Price
$39.13
Total value
$40.8K
InsiderCallos Andrew
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 8, 2025
Filing dateDecember 8, 2025
Shares owned after51,702
OwnershipDirect
10b5-1 planNo
AmendedNo